These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1863104)

  • 61. Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency.
    Tuchman M; Mauer SM; Holzknecht RA; Summar ML; Vnencak-Jones CL
    J Inherit Metab Dis; 1992; 15(2):269-77. PubMed ID: 1356172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
    J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen.
    Tremblay GC; Qureshi IA
    Pharmacol Ther; 1993 Oct; 60(1):63-90. PubMed ID: 8127924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
    Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
    Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The response to L-carnitine and glycine therapy in isovaleric acidaemia.
    de Sousa C; Chalmers RA; Stacey TE; Tracey BM; Weaver CM; Bradley D
    Eur J Pediatr; 1986 Feb; 144(5):451-6. PubMed ID: 3956533
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation.
    Shigematsu Y; Bykov IL; Liu YY; Nakai A; Kikawa Y; Sudo M; Fujioka M
    J Inherit Metab Dis; 1994; 17(6):678-90. PubMed ID: 7707691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.
    Rutledge SL; Berry GT; Stanley CA; van Hove JL; Millington D
    J Inherit Metab Dis; 1995; 18(3):299-305. PubMed ID: 7474896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analytical method for urinary glutarylcarnitine, acetylcarnitine and propionylcarnitine with a carboxylic acid analyser and a reversed-phase column.
    Kidouchi K; Sugiyama N; Morishita H; Wada Y; Nagai S; Sakakibara J
    J Chromatogr; 1987 Dec; 423():297-303. PubMed ID: 3443662
    [No Abstract]   [Full Text] [Related]  

  • 73. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Severe ornithine transcarbamylase deficiency. Two and a half years' survival with normal development.
    Guibaud P; Baxter P; Bourgeois J; Louis JJ; Bureau J
    Arch Dis Child; 1984 May; 59(5):477-9. PubMed ID: 6428329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate.
    McCormick K; Viscardi RM; Robinson B; Heininger J
    Am J Med Genet; 1985 Oct; 22(2):291-9. PubMed ID: 4050860
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mass spectrometric analysis of metabolite excretion in five Japanese patients with the late-onset form of glutaric aciduria type II.
    Shimizu N; Yamaguchi S; Orii T; Previs SF; Rinaldo P
    Biol Mass Spectrom; 1991 Aug; 20(8):479-83. PubMed ID: 1768704
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of glutarylcarnitine in glutaric aciduria type 1 by carboxylic acid analyzer with an ODS reverse-phase column.
    Kidouchi K; Sugiyama N; Morishita H; Kobayashi M; Wada Y; Nohara D
    Clin Chim Acta; 1987 May; 164(3):261-6. PubMed ID: 3594917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acylcarnitine analysis in the investigation of myopathy.
    Moore SJ; Haites NE; Broom I; White I; Coleman RJ; Pourfarzam M; Morris AA
    J Inherit Metab Dis; 1998 Jun; 21(4):427-8. PubMed ID: 9700602
    [No Abstract]   [Full Text] [Related]  

  • 80. Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency.
    Hwu WL; Chien YH; Tang NL; Law LK; Lin CY; Lee NC
    J Inherit Metab Dis; 2007 Oct; 30(5):816. PubMed ID: 17703373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.